Skip to main content

Table 1 Patients’ background

From: Bone management in Japanese patients with prostate cancer: hormonal therapy leads to an increase in the FRAX score

Variables

number (%)

Total

1220 (100.0 %)

Brachy Therapy

547 (44.8 %)

 with neo-adjuvant HTx

336 (27.5 %)

 without HTx

211 (17.3 %)

Total Prostatectomy

200 (16.4 %)

 with adjuvant HTx

50 (4.1 %)

 without HTx

150 (12.3 %)

EBRT

267 (21.9 %)

 with HTx

229 (18.8 %)

 without HTx

38 (3.1 %)

Hormonal Tx only

187 (15.3 %)

Active surveillance

19 (1.6 %)